BDBM50344824 1-(4-chlorobenzyl)-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-hydroxyindolin-2-one::CHEMBL1779925
SMILES: OC1(C(=O)N(Cc2ccc(Cl)cc2)c2ccccc12)c1ccc2OCCOc2c1
InChI Key: InChIKey=IHLYQXYXUNPCPO-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sodium channel protein type 9 subunit alpha (Homo sapiens (Human)) | BDBM50344824 (1-(4-chlorobenzyl)-3-(2,3-dihydrobenzo[b][1,4]diox...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 480 | n/a | n/a | n/a | n/a | n/a | n/a |
Xenon Pharmaceuticals Inc. Curated by ChEMBL | Assay Description Inhibition of human NaV1.7 expressed in HEK293 cells by [14C]guanidinium influx assay | Bioorg Med Chem Lett 21: 3676-81 (2011) Article DOI: 10.1016/j.bmcl.2011.04.088 BindingDB Entry DOI: 10.7270/Q2PC32PJ | |||||||||||
More data for this Ligand-Target Pair |